Title : Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells.

Pub. Date : 2022 Feb 20

PMID : 35216449






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 AKT1/2 siRNA knockdown or inhibition of BCL-2 family members with navitoclax (ABT-263) in BAKP-KO cells further enhanced caspase-mediated apoptotic PARP cleavage. 2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid AKT serine/threonine kinase 1 Homo sapiens
2 AKT1/2 siRNA knockdown or inhibition of BCL-2 family members with navitoclax (ABT-263) in BAKP-KO cells further enhanced caspase-mediated apoptotic PARP cleavage. 2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid BCL2 apoptosis regulator Homo sapiens
3 AKT1/2 siRNA knockdown or inhibition of BCL-2 family members with navitoclax (ABT-263) in BAKP-KO cells further enhanced caspase-mediated apoptotic PARP cleavage. 2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid caspase 9 Homo sapiens
4 AKT1/2 siRNA knockdown or inhibition of BCL-2 family members with navitoclax (ABT-263) in BAKP-KO cells further enhanced caspase-mediated apoptotic PARP cleavage. 2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid collagen type XI alpha 2 chain Homo sapiens